Sutro Biopharma, Inc.

General ticker "STRO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $237.9M (TTM average)

Sutro Biopharma, Inc. does not follow the US Stock Market performance with the rate: -2.0%.

Estimated limits based on current volatility of 17.3%: low 0.79$, high 1.12$

Factors to consider:

  • Current price 24.3% below estimated low

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.19$, 3.72$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.29$, 3.76$]

Financial Metrics affecting the STRO estimates:

  • Negative: Non-GAAP EPS, $ of -3.02 <= 0.04
  • Negative: Operating cash flow per share per price, % of -51.49 <= 1.79
  • Negative: negative Operating income
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82
  • Negative: Shareholder equity ratio, % of 11.52 <= 22.52
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Interest expense per share, $ of 0.40 <= 0.67

Similar symbols

Short-term STRO quotes

2025-03-142025-03-172025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-250.50.60.70.80.911.11.21.3
Price $

Long-term STRO plot with estimates

1234567Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−1−0.50
STROS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $67.77MM $153.73MM $62.04MM
Operating Expenses $196.72MM $243.01MM $300.50MM
Operating Income $-128.94MM $-89.28MM $-238.45MM
Non-Operating Income $12.24MM $0.68MM $13.36MM
Interest Expense $0.00MM $12.57MM $31.07MM
R&D Expense $137.17MM $180.43MM $252.04MM
Income(Loss) $-116.70MM $-88.60MM $-225.10MM
Taxes $2.50MM $18.19MM $2.36MM
Profit(Loss)* $-119.20MM $-106.79MM $-227.46MM
Stockholders Equity $217.05MM $149.65MM $44.60MM
Inventory $11.67MM $0.00MM $0.00MM
Assets $406.94MM $470.74MM $387.21MM
Operating Cash Flow $3.55MM $-111.62MM $-191.54MM
Capital expenditure $7.86MM $4.32MM $3.10MM
Investing Cash Flow $-35.02MM $-3.92MM $218.51MM
Financing Cash Flow $48.31MM $137.55MM $94.05MM
Earnings Per Share** $-2.35 $-1.78 $-2.96

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.